Iberogast Neo (Extract Of Iberis Amara (1 : 1.5 - 2.5), Extracting Agent: Ethanol 50 % (V/V), Liquid Extract Of Car)

Iberogast Neo is used to address functional gastrointestinal disturbances, particularly in the upper digestive tract.

• Functional dyspepsia: helps reduce bloating, early satiety and upper abdominal discomfort.
• Irritable bowel syndrome (IBS): may alleviate abdominal pain and irregular bowel habits.
• Non‑ulcer dyspepsia: supports relief of indigestion symptoms without ulcer disease.

• The extract of Iberis amara contains multiple phytochemicals that exert spasmolytic, anti‑inflammatory and pro‑secretory actions on the gastrointestinal tract. These compounds modulate smooth‑muscle tone, enhance mucosal protection and influence gastric motility, contributing to improved digestive function.

Iberogast Neo may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

• Mild abdominal discomfort: transient stomach upset.
• Altered taste: temporary metallic or bitter sensation.
• Headache: occasional mild headache.
• Nausea: occasional feeling of queasiness.
• Allergic skin rash: mild erythema or itching.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Hepatotoxicity: rare liver enzyme elevation.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Angioedema: swelling of face, lips or throat.
• Persistent vomiting: prolonged episodes beyond initial use.

When considering Iberogast Neo, observe the following precautions:

• Age restriction: use in adults only unless advised by a healthcare professional.
• Pregnancy and lactation: consult a physician before use during pregnancy or breastfeeding.
• Known hypersensitivity: avoid if allergic to Iberis amara or any formulation components.
• Concomitant herbal products: discuss with a clinician to prevent overlapping effects.
• Medical conditions: inform a doctor of any liver, kidney or gastrointestinal disorders.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Iberogast Neo may interact with certain medications; monitor accordingly.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Antiplatelet agents (e.g., aspirin, clopidogrel): potential additive antithrombotic effect.

Moderate Interactions (Monitor Closely)

• CYP450 substrates (e.g., midazolam, cyclosporine): possible alteration of drug metabolism.
• Proton pump inhibitors: may affect gastric pH and herb absorption.
• Other gastrointestinal motility agents: risk of additive spasmolytic activity.
• Herbal supplements containing similar botanicals: potential cumulative effects.